Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia.
about
Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future PerspectivesCooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma ModelsHow to develop viruses into anticancer weapons.Release the hounds: virotherapy with immunotherapy.Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy.Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy.Oncolytic Virotherapy: A Contest between Apples and Oranges.Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade.Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.Review: Oncolytic virotherapy, updates and future directions.Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma.Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.Designing and building oncolytic viruses.The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses.Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy.Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy.Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".Oncolytic Viruses for Multiple Myeloma Therapy.Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.Oncolytic virus and PD-1/PD-L1 blockade combination therapy
P2860
Q33679505-55B3BED5-C0F8-4207-8E91-EAA3E06ABEC4Q33725706-6FE0BF34-33CE-4A38-A740-A350404FCC85Q36310887-24AEE5CF-1DB3-4DA5-8C6C-4B3F906F34B2Q36700466-D756EFA9-19EE-4E3B-A4E1-CCFC9933D59DQ38746023-969DD548-6885-414E-AA2A-F0755A917BFEQ38941936-FDE1B821-F0DB-4675-B000-87A97B7CE00CQ39230055-525E3D01-5FAC-4650-8139-7C001E41FBEDQ39389626-B878D7B5-69FA-469A-820C-2809828251B2Q40082476-8E95DC81-3D04-4332-93AF-7C474C5A147CQ45324769-854BDD59-0C71-48D6-9074-34A79EC37876Q47160989-0F478F34-E9A0-4FE6-BA98-805352F71C68Q47326177-5FFFC8D0-239A-4C1A-9516-AC63C1984EC6Q47365404-89741559-D12F-4095-BD44-D87A1F85D2FCQ47547386-CC67E39C-41E3-47FE-8033-BA01E64294F9Q52594999-D5FFA1DF-9554-4834-88EB-18DAFFBF6888Q52688581-8650F7AB-C59C-4F11-B3F1-39A5058B6268Q54221621-4CBB633B-AAAC-4EE9-8671-F79BFEC5DA75Q54378300-B2D3B21B-6696-423F-B181-B9727AE6F701Q55515625-60F78CB7-AF70-4E30-81B5-49B34B087A52Q55652233-F280B23E-185E-430E-91D4-8D6347C02674Q57174025-C8B9D077-C28D-4986-A94B-61457CEB117D
P2860
Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immunovirotherapy with vesicul ...... murine acute myeloid leukemia.
@ast
Immunovirotherapy with vesicul ...... murine acute myeloid leukemia.
@en
type
label
Immunovirotherapy with vesicul ...... murine acute myeloid leukemia.
@ast
Immunovirotherapy with vesicul ...... murine acute myeloid leukemia.
@en
prefLabel
Immunovirotherapy with vesicul ...... murine acute myeloid leukemia.
@ast
Immunovirotherapy with vesicul ...... murine acute myeloid leukemia.
@en
P2093
P2860
P1433
P1476
Immunovirotherapy with vesicul ...... murine acute myeloid leukemia.
@en
P2093
Autumn Ruiz
Mrinal M Patnaik
Weiwei Shen
P2860
P304
P356
10.1182/BLOOD-2015-06-652503
P407
P577
2015-12-28T00:00:00Z